We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
AUM
$61.1M
AUM Growth
-$266K
Cap. Flow
-$5.25M
Cap. Flow %
-8.59%
Top 10 Hldgs %
31.78%
Holding
108
New
30
Increased
19
Reduced
22
Closed
32

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.88M
2
AET
Aetna Inc
AET
+$1.8M
3
BAX icon
Baxter International
BAX
+$1.22M
4
MCK icon
McKesson
MCK
+$1.04M
5
UNH icon
UnitedHealth
UNH
+$1.03M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$2.28M
2
AGN
Allergan plc
AGN
+$1.83M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.81M
4
AAPL icon
Apple
AAPL
+$1.65M
5
GILD icon
Gilead Sciences
GILD
+$1.6M

Sector Composition

Rank Sector Weight
1 Healthcare 40.86%
2 Technology 8.54%
3 Communication Services 4.28%
4 Financials 4.21%
5 Energy 3.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHTR icon
76
Charter Communications
CHTR
$18.3B
-2,473
Closed -$501K
CRM icon
77
Salesforce
CRM
$158B
-6,080
Closed -$449K
DVA icon
78
DaVita
DVA
$12B
-4,544
Closed -$333K
DXCM icon
79
DexCom
DXCM
$31.2B
-15,192
Closed -$258K
EEM icon
80
CALL
iShares MSCI Emerging Markets ETF
EEM
$29.5B
-12,300
Closed -$421K
ELV icon
81
Elevance Health
ELV
$84.8B
-11,268
Closed -$1.57M
GILD icon
82
Gilead Sciences
GILD
$164B
-17,379
Closed -$1.6M
GOOGL icon
83
Alphabet (Google) Class A
GOOGL
$4.43T
-35,340
Closed -$1.35M
HYG icon
84
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
-6,000
Closed -$490K
IBB icon
85
iShares Biotechnology ETF
IBB
$9.47B
-3,765
Closed -$327K
JD icon
86
JD.com
JD
$43.9B
-3,985
Closed -$106K
HAPN
87
Happen Inc
HAPN
$2.36B
-17,008
Closed -$706K
LRCX icon
88
Lam Research
LRCX
$385B
-189,980
Closed -$1.57M
MKTX icon
89
MarketAxess Holdings
MKTX
$5.71B
-1,819
Closed -$227K
NFLX icon
90
Netflix
NFLX
$309B
-63,990
Closed -$654K
OEF icon
91
CALL
iShares S&P 100 ETF
OEF
$20.4B
-8,000
Closed -$2.09M
PYPL icon
92
PayPal
PYPL
$49.6B
-25,731
Closed -$993K
SAGE
93
DELISTED
Sage Therapeutics
SAGE
-4,201
Closed -$135K
SYF icon
94
Synchrony
SYF
$25.8B
-30,545
Closed -$875K
TCOM icon
95
Trip.com Group
TCOM
$28.9B
-8,431
Closed -$373K
XBI icon
96
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.99B
-9,300
Closed -$480K
PXD
97
DELISTED
Pioneer Natural Resource Co.
PXD
-1,540
Closed -$217K
RAD
98
DELISTED
Rite Aid Corporation
RAD
-2,471
Closed -$403K
ACOR
99
DELISTED
Acorda Therapeutics
ACOR
-93
Closed -$296K
CLVS
100
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
-13,400
Closed -$257K

Similar funds

Partner Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Partner Investment Management held 108 positions worth $61.1M, down 0.43% from $61.4M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Partner Investment Management withdrew a net $5.25M in Q2 2016, closing 32 positions and reducing 22 holdings. Its most notable exit was Allergan plc, an estimated $1.83M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Partner Investment Management opened a new position in Biogen worth $1.73M.

  • Partner Investment Management's largest Q2 2016 buy was Biogen: 7,139 shares worth $1.73M.
  • Partner Investment Management added most to Aetna Inc in Q2 2016, an estimated $1.8M increase.
  • Partner Investment Management's biggest Q2 2016 reduction was HCA Healthcare, cutting an estimated $2.28M.
  • Partner Investment Management fully exited Allergan plc in Q2 2016, selling an estimated $1.83M.
  • Partner Investment Management's ten largest holdings make up 32% of its $61.1M portfolio in Q2 2016.
  • Partner Investment Management opened 30 new positions and closed 32 in Q2 2016.
  • Partner Investment Management's portfolio value fell 0.43% quarter-over-quarter to $61.1M.

Based on Partner Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.